ANZBMS-IFMRS-JSBMR 2017* , ,
Presentations this author is a contributor to:
Osteoclasts utilize TRAIL for their NF-κB activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts (#119)
5:00 PM
Hirofumi Tenshin
Welcome Reception & ANZBMS Plenary Posters
Novel targets of treatment for myeloma-bone interaction (#91)
8:30 AM
Masahiro Abe
Cancer & bone